1. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
   Fan Yang et al, 2023, Cell Metabolism CrossRef
2. Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis
   Aoyu Fan et al, 2024, Apoptosis CrossRef
3. Development and Validation of Ferroptosis-Related lncRNAs as Prognosis and Diagnosis Biomarkers for Breast Cancer
   Zhi-Yong Yao et al, 2022, BioMed Research International CrossRef
4. Identification of ferroptosis related genes and pathways in prostate cancer cells under erastin exposure
   Fan Wu et al, 2024, BMC Urology CrossRef
5. Roles of ferroptosis in urologic malignancies
   Shankun Zhao et al, 2021, Cancer Cell International CrossRef
6. HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation
   Junyu Chen et al, 2022, Oncology Reports CrossRef
7. Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
   Aino Siltari et al, 2022, Cancers CrossRef
8. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients
   Dechao Feng et al, 2023, European Journal of Medical Research CrossRef
9. CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation
   Juan Wang et al, 2024, Journal of Gastroenterology CrossRef
10. LncRNA A2M-AS1 Promotes Ferroptosis in Pancreatic Cancer via Interacting With PCBP3
    Xin Qiu et al, 2022, Molecular Cancer Research CrossRef
11. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer
    Mengjun Huang et al, 2024, Biomaterials Science CrossRef
12. YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH
    Xian Fu et al, 2023, Molecular and Cellular Biochemistry CrossRef
13. Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
    Pham Hong Anh Cao et al, 2024, Nature Reviews Urology CrossRef
14. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective
    Jiaming Liang et al, 2023, Cell Death Discovery CrossRef
15. The role of ferroptosis in prostate cancer: a novel therapeutic strategy
    Yue Wang et al, 2023, Prostate Cancer and Prostatic Diseases CrossRef
16. Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy
    Wei Fu et al, 2024, The Prostate CrossRef
17. Regulated Cell Death in Urinary Malignancies
    Zhenyu Nie et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
18. Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis
    Xiao-Dong Huang et al, 2022, Asian Journal of Surgery CrossRef
19. Ferroptosis Induction Improves the Sensitivity of Docetaxel in Prostate Cancer
    Xiumei Chen et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
20. MT1G, an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
    Bisheng Cheng et al, 2024, Environmental Toxicology CrossRef
21. Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
    Zhengtong Lv et al, 2021, Frontiers in Cell and Developmental Biology CrossRef